title: Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy.
authors.forename: G A
authors.initials: GA
authors.lastname: Fyfe
authors.forename: R I
authors.initials: RI
authors.lastname: Fisher
authors.forename: S A
authors.initials: SA
authors.lastname: Rosenberg
authors.forename: M
authors.initials: M
authors.lastname: Sznol
authors.forename: D R
authors.initials: DR
authors.lastname: Parkinson
authors.forename: A C
authors.initials: AC
authors.lastname: Louie
mesh_terms: D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins